MELANOMA BRAF V600E/K MUTATED

Clinical trials for MELANOMA BRAF V600E/K MUTATED explained in plain language.

Never miss a new study

Get alerted when new MELANOMA BRAF V600E/K MUTATED trials appear

Sign up with your email to follow new studies for MELANOMA BRAF V600E/K MUTATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Two-Step attack on deadly melanoma brain tumors

Disease control Recruiting now

This study is testing a two-step treatment for people with advanced melanoma that has spread to the brain and is causing symptoms. First, patients take two pills (encorafenib and binimetinib) for about two months. Then, they receive two intravenous drugs (cemiplimab and fianlimab…

Matched conditions: MELANOMA BRAF V600E/K MUTATED

Phase: PHASE2 • Sponsor: Grupo Español Multidisciplinar de Melanoma • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

MELANOMA BRAF V600E/K MUTATED

Get alerted when new MELANOMA BRAF V600E/K MUTATED trials appear

New Two-Step attack on deadly melanoma brain tumors